Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
This study has been withdrawn prior to enrollment.
(Unable to enroll patients)
Sponsor:
Regeneron Pharmaceuticals
Collaborator:
INC Research
Information provided by:
Regeneron Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00609544
First received: December 10, 2007
Last updated: April 17, 2011
Last verified: April 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |